Effect of pregnancy on the course of multiple sclerosis
https://doi.org/10.21518/2079-701X-2015-7-23-27
Abstract
Multiple sclerosis (MS) is an immune-mediated chronic inflammatory disorder of the central nervous system (CNS) often causing disability in young adults. As is the case with the majority of autoimmune diseases, multiple sclerosis patients are predominantly women - 2.5 times more often than men. [1-4, 13] Considering the fact that the disease onset mainly occurs in childbearing age, it becomes clear why so much attention has been recently given to the possibility of pregnancy for patients with multiple sclerosis.
About the Authors
A. I. Мuravin
First Moscow State Medical University named after I.M. Sechenov, Russian Medical Research University named after N.I. Pirogov, Moscow
Russian Federation
Russian Federation
А. N. Boyko
First Moscow State Medical University named after I.M. Sechenov, Russian Medical Research University named after N.I. Pirogov, Moscow ; City Clinical Hospital №24, Moscow
Russian Federation
Russian Federation
E. V. Popova
First Moscow State Medical University named after I.M. Sechenov, Russian Medical Research University named after N.I. Pirogov, Moscow ; City Clinical Hospital №24, Moscow
Russian Federation
Russian Federation
A. V. Murashkо
First Moscow State Medical University named after I.M. Sechenov, Russian Medical Research University named after N.I. Pirogov, Moscow
Russian Federation
Russian Federation
References
1. Гусев ВА., Холопов Б.К. О провоцирующем влиянии беременности, родов и послеродового периода на различные формы рассеянного склероза. Советская медицина. 1978. 12. 31-33.
2. Гусев Е.И., Завалишин И.А., Бойко А.Н. Рассеянный склероз. Клиническое руководство, 2011, 520.
3. Завалишин И.А., Невская О.М. Беременность и рассеянный склероз. Клиническая медицина. 1976. 54, 1. 101-105.
4. Зинченко А.П. Рассеянный склероз и энцефаломиелит (этиология, патогенез, лечение). Л.: Медицина, 1973. 295.
5. Лиджей В.Ю. Взаимосвязь беременности и рассеянного склероза. Нейроиммунология. 2005. 3, 2. 84-85.
6. Ненашева С.А., Круглова О.В., Балашова В.Н. Итоги 10-летнего мониторинга врожденных пороков развития в Самарской области (1999-2008). Мат. VIII Российского конгресса «Современные технологии в педиатрии и детской хирургии», 2009, 81-84.
7. Сидельникова В.М. с соавт., 2004; 2005; 2010; Стрижаков А.Н. с соавт., 2009; Савельева Г.М. с соавт., 2000; 2009; Макаров И.О. с соавт., 2009; Торчинов А.М., 2006.
8. Тимофеева Т.Ю., Леонов Г.А., Стариков А.С. и др. Об особенностях течения рассеянного склероза в гестационном периоде. Патология нервной системы у женщин репродуктивного возраста: сб. науч. тр. [под ред. А.С. Деева]. Рязань, 1993. 90-92.
9. Ушкалова Е., Ткачева О., Чукарева Н. Применение лекарственных средств у беременных женщин. Врач, 2010: 7; 22-25.
10. Шмидт Т.Е., Яхно Н.Н. Рассеянный склероз. М.: Медицина, 2003; 76-138.
11. Hutchinson M. Улучшает или ухудшает беременность рассеянный склероз? Рассеянный склероз. Клинические аспекты и спорные вопросы [под ред. А. Томпсона, К. Полмана, Р. Холфельда]. СПб.: Политехника, 2001. 150-155.
12. Birk K, Rudick R. Pregnancy and multiple sclerosis. Arch Neurol 1986; 43: 719e26.
13. Boyko AN, Kesselring J, Paty DW et al. Multiple sclerosis and public health. Education, Departament of Mental Health, Neurological Disorders 1999; 2: 1-11.
14. Cree BA. Update on reproductive safety of current and emerging disease-modifying therapies for multiple sclerosis. Mult Scler J. 2013; 19: 835-43.
15. Douglass LH, Jorgensen CL. Pregnancy and multiple sclerosis. Am J Obstet Gynegol 1948; 55: 332e6. [2] 20.
16. Finkelsztejn A, Brooks JBB, Paschoal FM, Fragoso YD. What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and metaanalysis of the literature. BJOG 2011; 118: 790e7.
17. Formby B. Immunologic response in pregnancy. Its rolw in endocrine disorders of pregnancy and influence on the course of maternal autoimmune diseases. Endocrinol Metab Clin B Am 1995; 24: 187-205.
18. Golmore W, Ariad M, Stroud N, Stek A, McCarty KA, Correale J. Preliminary studies of cytokine secretion patterns associated with pregnancy in MS patients. J Neurol Sci 2004; 224; 69-76.
19. Herring C, McManus A, Weeks A. Off-label prescribing during pregnancy in the UK: an analisis of 18000 prescriptions in Liverpool Women's Hospital. Int J Pharm Pract., 2010; 18: 9-226.
20. Hill JA, Polgar K, Anderson DJ. T-helper 1 -type immunity to trophoblast in women with recurrent spontaneous abortion. JAMA 1995, 273: 1933-1936.
21. Lu E et al. Safety of disease-modifying drugs for multiple sclerosis in pregnancy: current challenges and future considerations for effective pharmacovigilance. Expert RevNeurother. 2013; 13(3): 251-60. quiz 261.
22. Neurol Ther (2014) 3: 133-138 DOI 10.1007/ s40120-014-0020-y Pregnancy Outcomes Following Maternal and Paternal Exposure to Teriflunomide During Treatment for Relapsing-Remitting Multiple Sclerosis.
23. Niino M, et al. Natalizumab effects on immune cell responses in mul-tiple sclerosis. Ann Neurol. 2006; 59(5): 748-54.
24. Runmarker B, Andersen O. Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis. Brain 1995;118: 253e61.
25. Sandberg-Wollheim M, et al. Pregnancy outcomes in multiple sclerosis following subcutaneous interferon beta-1a therapy. Mult Scler. 2011; 17(4): 423-30.
26. Van Walderveen MAA, Tas MW, Barkhof F et al. Magnetic resonance evaluation of disease activity during pregnancy in MS. Neurology 1994; 44:327-329.
27. Verdru P, Theys P, D'hooghe MB, Carton H. Pregnancy and multiple sclerosis: the influence on long term disability. Clin Neurol Neurosurg 1994; 96: 38e41.
28. Voskuhl R. Sex hormones and other pregnancy-related factors with therapeutic potential in multiple sclerosis. In: D. Cohen, R. Rudick, eds. MS Therapeutics. London: Martin Dunitz Ltd 2003; 32: 535-549.
Review
For citations:
Мuravin AI, Boyko АN, Popova EV, Murashkо AV. Effect of pregnancy on the course of multiple sclerosis. Meditsinskiy sovet = Medical Council. 2015;(7):23-27. (In Russ.) https://doi.org/10.21518/2079-701X-2015-7-23-27
Views:
1188
Email this article 